In this trial, PD-L1 positivity was defined as over 1% PD-L1 expression in cancer cells or any staining in the tumor stroma and increasing expression of PD-L1 was associated with anti-PD-1 antibody response. This evidence concerns the gene CD274 and neoplasm.